DE3683844D1 - Impfstoff des klebsiella kapsulpolysaccharids. - Google Patents

Impfstoff des klebsiella kapsulpolysaccharids.

Info

Publication number
DE3683844D1
DE3683844D1 DE8686302311T DE3683844T DE3683844D1 DE 3683844 D1 DE3683844 D1 DE 3683844D1 DE 8686302311 T DE8686302311 T DE 8686302311T DE 3683844 T DE3683844 T DE 3683844T DE 3683844 D1 DE3683844 D1 DE 3683844D1
Authority
DE
Germany
Prior art keywords
polysaccharides
capsular
klebsiella
serotype
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686302311T
Other languages
German (de)
English (en)
Inventor
Stanley J Cryz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cilag GmbH International
Original Assignee
Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten filed Critical Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten
Application granted granted Critical
Publication of DE3683844D1 publication Critical patent/DE3683844D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8686302311T 1986-03-27 1986-03-27 Impfstoff des klebsiella kapsulpolysaccharids. Expired - Lifetime DE3683844D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP86302311A EP0238739B1 (en) 1986-03-27 1986-03-27 Klebsiella capsular polysaccharide vaccine
ZA862478A ZA862478B (https=) 1986-03-27 1986-04-03

Publications (1)

Publication Number Publication Date
DE3683844D1 true DE3683844D1 (de) 1992-03-19

Family

ID=26103944

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686302311T Expired - Lifetime DE3683844D1 (de) 1986-03-27 1986-03-27 Impfstoff des klebsiella kapsulpolysaccharids.

Country Status (4)

Country Link
EP (1) EP0238739B1 (https=)
AT (1) ATE72401T1 (https=)
DE (1) DE3683844D1 (https=)
ZA (1) ZA862478B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10194979A (ja) * 1997-01-07 1998-07-28 Teika Corp イムノグロブリンｅ抗体産生抑制剤
KR100757630B1 (ko) * 1997-12-23 2007-09-10 박스터 헬쓰케어 에스.에이. 신규한 추출 및 단리 방법으로 수득되는 세균성 캡슐형 다당류
EP1976857A4 (en) * 2006-01-13 2011-08-03 Baxter Int PROCESS FOR CLEANING POLYSACCHARIDES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510606A1 (fr) * 1981-07-30 1983-02-04 Berri Balzac Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins

Also Published As

Publication number Publication date
EP0238739A1 (en) 1987-09-30
ZA862478B (https=) 1986-10-06
EP0238739B1 (en) 1992-02-05
ATE72401T1 (de) 1992-02-15

Similar Documents

Publication Publication Date Title
ATE326231T1 (de) Mutierendes enterotoxin als nichttoxisches orales adjuvans
CA2071811A1 (en) Improved meningococcal polysaccharide conjugate vaccine
IE791575L (en) Hepatitis a vaccine
ES8104403A1 (es) Procedimiento para purificar polisacaridos capsulares neumo-coccicos
LU91594I2 (fr) Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de virus poliomyélitique inactivé type 1, type 2 et type 3 (Infanrix - IPV)
ATE125568T1 (de) Analoge der untereinheit des von rekombinanter dns abgeleiteten bordetella-toxins.
BR9714980A (pt) Vacinas multivalentes
DK320786D0 (da) Vaccine
HUT63770A (en) Conjugated vaccine against microorganisms belonging to streptococcus 8 group
DE3683844D1 (de) Impfstoff des klebsiella kapsulpolysaccharids.
GR870917B (en) Novel mehthod of preparing toxoid
DE69113991D1 (de) Impfstoff.
IL67818A (en) Vaccines comprising ozone inactivated viruses and their production
ES2059605T3 (es) Vacuna toxoide de la tosferina.
NL300073I1 (nl) Vaccin.
CA2112225A1 (en) Attenuated revertant serotype 1 marek's disease vaccine
PL217216A1 (https=)
DE3750549D1 (de) Impfstoff gegen schweinedysenterie.
Abecassis et al. Prostaglandin E2 (PGE2) alters the pathogenesis of MHV-3 infection in susceptible BALB/cJ mice
DU Several Pseudomonas aeruginosa-LPS-containing Preparations and Their Protection against Pseudomonas aeruginosa Infection
Likhoded et al. Evaluation of the immunogenicity of vaccine prepared from Salmonella minnesota mutant R 595 on the model of experimental Pseudomonas aeruginosa infection in mice.
WO2024025936A3 (en) Development of carbohydrate-based anti-salmonella vaccines
Sriburadej et al. Burn and cardiac infection: A case report.
Vysushkow Prophylaxis of acute intestinal infections of the basis of the system of epidemiological surveillance.
XU Establishment of consensus sequence of PreS/S and Enhll/CP/PreC of hepatitis B virus prevailing in Chongqing, China

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee